Etiket: Sanofi
Sanofi stops developing drug candidates for lung cancer
By Adria Calatayud PARIS (Dow Jones)–Sanofi wants to end the clinical development program for the drug candidate Tusamitamab Ravtansine. The reason is that a study in late-stage non-small cell lung…
ANALYSIS FLASH: UBS leaves Sanofi at ‘neutral’ – target 100 euros
ZURICH (dpa-AFX Broker) – The major Swiss bank UBS has left Sanofi’s rating at “neutral” with a price target of 100 euros based on quarterly figures and lowered expectations for…
Sanofi shares slightly red: Sanofi is planning a spin-off from its consumer healthcare business
The pharmaceutical company Sanofi is following its competitors and planning to spin off its consumer healthcare business into a listed company. As the French company announced on Friday, the spin-off…
Outlook: Sanofi presents balance sheet figures for the most recent quarter of the year
Sanofi opens the books – that’s what analysts expect. Sanofi will present the quarterly figures for the most recent quarter – closing date September 30, 2023 – at the financial…
Sanofi and Janssen collaborate on Escherichia coli vaccine
By Adria Calatayud FRANKFURT (Dow Jones)–Sanofi and Johnson & Johnson’s Janssen Pharmaceuticals division have entered into a development and commercialization agreement for a vaccine candidate against extraintestinal pathogenic Escherichia coli.…
ROUNDUP: After a strong year, Sanofi expects less earnings growth in 2023
shares in this article indexes in this article PARIS (dpa-AFX) – Thanks to its blockbuster Dupixent, the pharmaceutical company Sanofi has grown significantly in the past year. In the final…
Sanofi halts development program for breast cancer drug amcenestrant
To make it easier for you to keep track of the large number of messages that appear every day for a company, we have divided the news feed into the…
Sanofi and GSK: booster shot strengthens defenses against omikron variant
The pharmaceutical companies Sanofi and GSK, which last year stopped developing their own corona vaccine, claim that their experimental booster shot elicits a more potent immune response against variants of…
Booster vaccine from Sanofi and GSK elicits strong immune response | medical
Sanofi’s new booster shot induces a significant rise in antibodies against worrisome corona variants. This is apparent from the results of two studies, reports the French pharmaceutical company. The jab…